Immediate Reconstruction and Dental Rehabilitation of Maxillofacial Defects

首次发布于 2017 年 12 月 12 日

Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

计划入组 18 人 · 首次发布于 2020 年 1 月 23 日

A Study on Ketoprofen Lysine Salt (KLS) + Gabapentin (GABA) vs KLS to Investigate Their Pharmacodynamic in Healthy Males

计划入组 141 人 · 首次发布于 2021 年 3 月 17 日

KLS-2030

KLS-3021

KLS-0611

Martin Ekwealor Pharmaceu

United States

MARTIN & PLEASANCE WHOLESALE PTY. LTD.

Australia

Martin Ekwealor Pharmaceuticals, Inc.

United States

Global Bioresorbable Polymers Market to Reach USD 867.2 Million by 2029, Growing at 11.6% CAGR

Azenta Appoints Dr. Martin Madaus as Interim CEO Amid Leadership Transition

Molecular Partners Appoints Martin Steegmaier as Chief Scientific Officer to Advance DARPin Therapeutics Pipeline